Most Men With Low-Risk Prostate Tumors Now Forgoing Treatment

Acceptance of active surveillance for low-risk prostate cancer hit a record high in 2021, although the US still lags internationally, new figures showed.
Medscape Medical News

source https://www.medscape.com/viewarticle/974009?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?